Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

JAZZ Q3 2016 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$374M

Gross Profit

$350M93.5% margin

Operating Income

$136M36.4% margin

Net Income

$87M23.3% margin

EPS (Diluted)

$1.45

QoQ Revenue Growth

-1.8%

Cash Flow

Operating Cash Flow

$137M

Free Cash Flow

$119M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$4.9B

Total Liabilities

$3.2B

Stockholders' Equity

$1.7B

Cash & Equivalents

$367M

Revenue Segments

Defitelio

$28M100%

Geographic Segments

UNITED STATES

$340M91%

Europe

$26M7%

Other Countries

$9M2%

← FY 2016 All Quarters Q4 2016 →